---
{"dg-publish":true,"permalink":"/research-notes/psychedelics-and-neuroplasticity/","tags":["#researchnotes","✏️"]}
---

# Psychedelics and neuroplasticity
## A starter bibliography

>Ornelas, I. M., Cini, F. A., Wießner, I., Marcos, E., de Araújo, D., Goto-Silva, L., Nascimento, J., Silva, S. R. B., Costa, M. N., Falchi, M., Olivieri, R., Palhano-Fontes, F., Sequerra, E., Martins-de-Souza, D., Feilding, A., Rennó-Costa, C., Tófoli, L. F., Rehen, S. K., & Ribeiro, S. (2022). Nootropic effects of LSD: Behavioral, molecular and computational evidence. _Experimental Neurology_, 114148. [https://doi.org/10.1016/j.expneurol.2022.114148](https://doi.org/10.1016/j.expneurol.2022.114148)

 

> Almeida, C. A. F., Pereira-Junior, A. A., Rangel, J. G., Pereira, B. P., Costa, K. C. M., Bruno, V., Silveira, G. O., Ceron, C. S., Yonamine, M., Camarini, R., Garcia, R. C. T., Marcourakis, T., & Torres, L. H. (2022). Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice. _Behavioural Brain Research_, _416_, 113546. [https://doi.org/10.1016/j.bbr.2021.113546](https://doi.org/10.1016/j.bbr.2021.113546)
> 
> Calder, A. E., & Hasler, G. (2022). Towards an understanding of psychedelic-induced neuroplasticity. _Neuropsychopharmacology_, 1–9. [https://doi.org/10.1038/s41386-022-01389-z](https://doi.org/10.1038/s41386-022-01389-z)
> 
> Du, Y., Li, Y., Zhao, X., Yao, Y., Wang, B., Zhang, L., & Wang, G. (2023). Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. _Chinese Medical Journal_, _Publish Ahead of Print_. [https://doi.org/10.1097/CM9.0000000000002647](https://doi.org/10.1097/CM9.0000000000002647)
> 
> Inserra, A., Campanale, A., Cheishvili, D., Dymov, S., Wong, A., Marcal, N., Syme, R. A., Taylor, L., De Gregorio, D., Kennedy, T. E., Szyf, M., & Gobbi, G. (2022). Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling. _Progress in Neuro-Psychopharmacology and Biological Psychiatry_, _119_, 110594. [https://doi.org/10.1016/j.pnpbp.2022.110594](https://doi.org/10.1016/j.pnpbp.2022.110594)
> 
> Jefferson, S. J., Gregg, I., Dibbs, M., Liao, C., Wu, H., Davoudian, P. A., Woodburn, S. C., Wehrle, P. H., Sprouse, J. S., Sherwood, A. M., Kaye, A. P., Pittenger, C., & Kwan, A. C. (2023). 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice. _Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology_. [https://doi.org/10.1038/s41386-023-01572-w](https://doi.org/10.1038/s41386-023-01572-w)
> 
> Lepow, L., Morishita, H., & Yehuda, R. (2023). Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy. _Focus (American Psychiatric Publishing)_, _21_(3), 329–336. [https://doi.org/10.1176/appi.focus.23021012](https://doi.org/10.1176/appi.focus.23021012)
> 
> Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., Duim, W. C., Dennis, M. Y., McAllister, A. K., Ori-McKenney, K. M., Gray, J. A., & Olson, D. E. (2018). Psychedelics promote structural and functional neural plasticity. _Cell Reports_, _23_(11), 3170–3182. [https://doi.org/10.1016/j.celrep.2018.05.022](https://doi.org/10.1016/j.celrep.2018.05.022)
> 
> Moliner, R., Girych, M., Brunello, C., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E., Goncharuk, S., Kaurinkoski, K., Kuutti, M., Fred, S., Elsilä, L., Sakson, S., Cannarozzo, C., Diniz, C., Seiffert, N., Rubiolo, A., Haapaniemi, H., & Castrén, E. (2023). Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. _Nature Neuroscience_, _26_. [https://doi.org/10.1038/s41593-023-01316-5](https://doi.org/10.1038/s41593-023-01316-5)
> 
> Skosnik, P. D., Sloshower, J., Safi-Aghdam, H., Pathania, S., Syed, S., Pittman, B., & D’Souza, D. C. (2023a). Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. _Journal of Psychopharmacology (Oxford, England)_, _37_(7), 687–697. [https://doi.org/10.1177/02698811231179800](https://doi.org/10.1177/02698811231179800)
> 
> Sumner, R., & Lukasiewicz, K. (2023a). Psychedelics and neural plasticity. _BMC Neuroscience_, _24_(1), 35. [https://doi.org/10.1186/s12868-023-00809-0](https://doi.org/10.1186/s12868-023-00809-0)
> 
> Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., McCorvy, J. D., Gray, J. A., Tian, L., & Olson, D. E. (2023). Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. _Science (New York, N.Y.)_, _379_(6633), 700–706. [https://doi.org/10.1126/science.adf0435](https://doi.org/10.1126/science.adf0435)

 

> Bombaci, B. (n.d.). _Defending Perceptual Diversity in America: Entheogens as Legitimate Contributors to Learning, Health, and Empathy_. 34.
> 
> Buchborn, T., Schröder, H., Höllt, V., & Grecksch, G. (2014). Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT 2 signalling. _Journal of Psychopharmacology_, _28_(6), 545–552. [https://doi.org/10.1177/0269881114531666](https://doi.org/10.1177/0269881114531666)
> 
> Grinspoon, L., & Bakalar, J. B. (1997). _Psychedelic Drugs Reconsidered, The Lindesmith Center. (Specifically “Learning and Creativity,” pp. 261–267 in Chapter 7 “Psychedelic Drugs and the Human Mind.”) Originally published in 1979 by Basic Books, Inc., a division of Harper Colophon Books_.
> 
> HERTZ, M. (1963a). LSD-behandlingen som stress og katalysator for laereprocesser. [LSD-Treatments as a Stress Factor and Catalyst in Learning Processes]. _Nordisk Psykiatrisk Tidsskrift_, _17_, 169–177. [https://doi.org/10.3109/08039486309132762](https://doi.org/10.3109/08039486309132762)
> 
> HERTZ, M. (1963b). _LSD-behandlingen som stress og katalysator for laereprocesser. [LSD-Treatments as a Stress Factor and Catalyst in Learning Processes.] Nordisk Psykiatrisk Tidsskrift 17: 169-177_.
> 
> HERTZ, M. (1967). _The Mechanism of the LSD Treatment as Viewed from the Aspect of Learning Processes. In: Abramson, Harold A. (ed.): The Use of LSD in Psychotherapy and Alcoholism. Indianapolis/New York/Kansas City: Bobbs Merrill 1967, pp_. 661–669.
> 
> HERTZ, M. (1968). LSD Stress and Learning. _Acta Psychiatrica Scandinavica_, _203_(Suppl.), 201–204. [https://doi.org/10.1111/j.1600-0447.1968.tb01991.x](https://doi.org/10.1111/j.1600-0447.1968.tb01991.x)
> 
> Kanen, J. W., Luo, Q., Kandroodi, M. R., Cardinal, R. N., Robbins, T. W., Nutt, D. J., Carhart-Harris, R. L., & Ouden, H. E. M. den. (2022). Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. _Psychological Medicine_, 1–12. [https://doi.org/10.1017/S0033291722002963](https://doi.org/10.1017/S0033291722002963)
> 
> Nardou, R., Sawyer, E., Song, Y. J., Wilkinson, M., Padovan-Hernandez, Y., de Deus, J. L., Wright, N., Lama, C., Faltin, S., Goff, L. A., Stein-O’Brien, G. L., & Dölen, G. (2023). Psychedelics reopen the social reward learning critical period. _Nature_, _618_(7966), Article 7966. [https://doi.org/10.1038/s41586-023-06204-3](https://doi.org/10.1038/s41586-023-06204-3)
> 
> Romano, A. G., Quinn, J. L., Li, L., Dave, K. D., Schindler, E. A., Aloyo, V. J., & Harvey, J. A. (2010). Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit, Romano et al. _Psychopharmacology_, _212_(3), 441–448. [https://doi.org/10.1007/s00213-010-2004-7](https://doi.org/10.1007/s00213-010-2004-7)

 
> Borbély, E., Varga, V., Szögi, T., Schuster, I., Bozsó, Z., Penke, B., & Fülöp, L. (2022). Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1–42-Injected, Wild-Type Mouse Model of AD. _International Journal of Molecular Sciences_, _23_(5), Article 5. [https://doi.org/10.3390/ijms23052514](https://doi.org/10.3390/ijms23052514)
> 
> Bremler, R., Katati, N., Shergill, P., Erritzoe, D., & Carhart-Harris, R. L. (2023a). Case analysis of long-term negative psychological responses to psychedelics. _Scientific Reports_, _13_(1), Article 1. [https://doi.org/10.1038/s41598-023-41145-x](https://doi.org/10.1038/s41598-023-41145-x)
> 
> Calder, A. E., & Hasler, G. (2022). Towards an understanding of psychedelic-induced neuroplasticity. _Neuropsychopharmacology_, 1–9. [https://doi.org/10.1038/s41386-022-01389-z](https://doi.org/10.1038/s41386-022-01389-z)
> 
> Catlow, B. J., Jalloh, A., & Sanchez-Ramos, J. (2016). Hippocampal Neurogenesis. In _Neuropathology of Drug Addictions and Substance Misuse_ (pp. 821–831). Elsevier. [https://doi.org/10.1016/B978-0-12-800212-4.00077-7](https://doi.org/10.1016/B978-0-12-800212-4.00077-7)
> 
> Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013). Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. _Experimental Brain Research_, _228_(4), 481–491. [https://doi.org/10.1007/s00221-013-3579-0](https://doi.org/10.1007/s00221-013-3579-0)
> 
> Cini, F. A., Ornelas, I., Marcos, E., Goto-Silva, L., Nascimento, J., Ruschi, S., Salerno, J., Karmirian, K., Costa, M., Sequerra, E., de Araújo, D., Tófoli, L. F., Rennó-Costa, C., Martins-de-Souza, D., Feilding, A., Rehen, S., & Ribeiro, S. (2019). _D-Lysergic acid diethylamide has major potential as a cognitive enhancer_ [Preprint]. Neuroscience. [https://doi.org/10.1101/866814](https://doi.org/10.1101/866814)
> 
> De Gregorio, D., Inserra, A., Enns, J. P., Markopoulos, A., Pileggi, M., El Rahimy, Y., Lopez-Canul, M., Comai, S., & Gobbi, G. (2022). Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. _Neuropsychopharmacology_, _47_(6), Article 6. [https://doi.org/10.1038/s41386-022-01301-9](https://doi.org/10.1038/s41386-022-01301-9)
> 
> Douglas, A., Staas, D., Hampton, A., Burns, K., & Suter, F. (2023). Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future. _Georgetown Scientific Research Journal_, _3_(2), 19–29. [https://doi.org/10.48091/gsr.v3i2.62](https://doi.org/10.48091/gsr.v3i2.62)
> 
> Du, Y., Li, Y., Zhao, X., Yao, Y., Wang, B., Zhang, L., & Wang, G. (2023). Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. _Chinese Medical Journal_, _Publish Ahead of Print_. [https://doi.org/10.1097/CM9.0000000000002647](https://doi.org/10.1097/CM9.0000000000002647)
> 
> Eloff, A. (2023a). _Undoing the Present, Crystallising the Future: Psychedelic Schizoanalysis_.> 
> Fissler, P., Vandersmissen, A., Filippi, M., Mavioglu, R. N., Scholkmann, F., Karabatsiakis, A., & Krähenmann, R. (2023a). Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies. _Journal of Psychopharmacology (Oxford, England)_, _37_(7), 679–686. [https://doi.org/10.1177/02698811231164707](https://doi.org/10.1177/02698811231164707)
> 
> Fissler, P., Vandersmissen, A., Filippi, M., Mavioglu, R. N., Scholkmann, F., Karabatsiakis, A., & Krähenmann, R. (2023b). Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies. _Journal of Psychopharmacology (Oxford, England)_, _37_(7), 679–686. [https://doi.org/10.1177/02698811231164707](https://doi.org/10.1177/02698811231164707)
> 
> Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R. B. S., & Idell, S. (2017). The fibrinolytic system: A new target for treatment of depression with psychedelics. _Medical Hypotheses_, _100_, 46–53. [https://doi.org/10.1016/j.mehy.2017.01.013](https://doi.org/10.1016/j.mehy.2017.01.013)
> 
> Inserra, A., Campanale, A., Cheishvili, D., Dymov, S., Wong, A., Marcal, N., Syme, R. A., Taylor, L., De Gregorio, D., Kennedy, T. E., Szyf, M., & Gobbi, G. (2022). Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling. _Progress in Neuro-Psychopharmacology and Biological Psychiatry_, _119_, 110594. [https://doi.org/10.1016/j.pnpbp.2022.110594](https://doi.org/10.1016/j.pnpbp.2022.110594)
> 
> Jones, N. T., Zahid, Z., Grady, S. M., Sultan, Z. W., Zheng, Z., Banks, M. I., & Wenthur, C. J. (2020). Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release. _bioRxiv_, 2020.08.12.248229. [https://doi.org/10.1101/2020.08.12.248229](https://doi.org/10.1101/2020.08.12.248229)
> 
> Kinderlehrer, D. A. (2023). The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study. _International Medical Case Reports Journal_, _16_, 109–115. [https://doi.org/10.2147/IMCRJ.S395342](https://doi.org/10.2147/IMCRJ.S395342)
> 
> Labate, B. C., & Cavnar, C. (Eds.). (2018). _Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives_. Springer International Publishing. [https://doi.org/10.1007/978-3-319-76720-8](https://doi.org/10.1007/978-3-319-76720-8)
> 
> Lee, H. J., Tsang, V. W., Chai, B. S., Lin, M. C., Howard, A., Uy, C., & Elefante, J. O. (2023). Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review. _Journal of Psychoactive Drugs_, 1–15. [https://doi.org/10.1080/02791072.2023.2223195](https://doi.org/10.1080/02791072.2023.2223195)
> 
> Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., Duim, W. C., Dennis, M. Y., McAllister, A. K., Ori-McKenney, K. M., Gray, J. A., & Olson, D. E. (2018). Psychedelics promote structural and functional neural plasticity. _Cell Reports_, _23_(11), 3170–3182. [https://doi.org/10.1016/j.celrep.2018.05.022](https://doi.org/10.1016/j.celrep.2018.05.022)
> 
> Magaraggia, I., Kuiperes, Z., & Schreiber, R. (2021a). Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach. _Neurobiology of Learning and Memory_, _183_, 107467. [https://doi.org/10.1016/j.nlm.2021.107467](https://doi.org/10.1016/j.nlm.2021.107467)
> 
> Martin, D. A., Marona-Lewicka, D., Nichols, D. E., & Nichols, C. D. (2014). Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia. _Neuropharmacology_, _83_, 1–8. [https://doi.org/10.1016/j.neuropharm.2014.03.013](https://doi.org/10.1016/j.neuropharm.2014.03.013)
> 
> Morales-Garcia, J. A., Calleja-Conde, J., Lopez-Moreno, J. A., Alonso-Gil, S., Sanz-SanCristobal, M., Riba, J., & Perez-Castillo, A. (2020). N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. _Translational Psychiatry_, _10_(1), Article 1. [https://doi.org/10.1038/s41398-020-01011-0](https://doi.org/10.1038/s41398-020-01011-0)
> 
> Morales-García, J. A., de la Fuente Revenga, M., Alonso-Gil, S., Rodríguez-Franco, M. I., Feilding, A., Perez-Castillo, A., & Riba, J. (2017). The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro. _Scientific Reports_, _7_(1), 5309. [https://doi.org/10.1038/s41598-017-05407-9](https://doi.org/10.1038/s41598-017-05407-9)
> 
> _Psychedelics Today: PTSF57 - New Compounds, Psychedelic Business, and Neurogenesis_. (n.d.). Retrieved April 30, 2021, from [https://psychedelicstoday.libsyn.com/ptsf57-new-compounds-psychedelic-business-and-neurogenesis-0](https://psychedelicstoday.libsyn.com/ptsf57-new-compounds-psychedelic-business-and-neurogenesis-0)
> 
> Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. _International Journal of Molecular Sciences_, _22_(2). [https://doi.org/10.3390/ijms22020835](https://doi.org/10.3390/ijms22020835)
> 
> Song, J., Kambari, Y., Amaev, A., Ueno, F., Torres Carmona, E., De Luca, V., Pollock, B., Flint, A., Husain, M. I., Graff-Guerrero, A., & Gerretsen, P. (2023). Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment. _Medical Hypotheses_, _175_, 111068. [https://doi.org/10.1016/j.mehy.2023.111068](https://doi.org/10.1016/j.mehy.2023.111068)
> 
> Winkelman, M. J., Szabo, A., & Frecska, E. (2023). The potential of psychedelics for the treatment of Alzheimer’s disease and related dementias. _European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology_, _76_, 3–16. [https://doi.org/10.1016/j.euroneuro.2023.07.003](https://doi.org/10.1016/j.euroneuro.2023.07.003)